Skip to main content
Top

Decoding Cardiac Maturation Program: Insights from RNA Splicing Regulation

  • 01-12-2025
  • Regenerative Medicine (SM Wu, Section Editor)
Published in:

Abstract

Purpose of Review

Cardiomyocyte postnatal maturation is a critical step of the mammalian heart development continuum, involving a myriad of phenotypic changes at morphological, molecular, and functional levels. While the phenotypic hallmarks of cardiac maturation are well characterized, the molecular mechanisms that govern this maturation process are still poorly defined. This review aims to explore the recent findings on how post-transcriptional regulations orchestrate the fetal-to-adult cardiomyocyte transition and to highlight their clinical implications for cardiac diseases and regeneration medicine.

Recent Findings

The molecular regulations of cardiac maturation are distinct from the gene regulatory network implicated in embryonic stages of cardiac development. RNA alternative splicing and the resulting isoform switching events are significant part of the post-transcriptional reprogramming during the transitional stage of maturation, driving functional refinement through a network of RNA-binding proteins.

Summary

Cardiomyocytes undergo significant changes in structure, physiology, metabolic activity, and proliferative capacities during fetal to adult maturation. Recent findings highlight the importance of post-transcriptional regulation in this process, in particular RNA alternative splicing and isoform switch. Understanding the post-transcriptional regulatory mechanisms, including key molecular players that contribute to the fetal-to-adult transition, can provide a new conceptual framework for cardiac development, diseases, and regenerative medicine.
Title
Decoding Cardiac Maturation Program: Insights from RNA Splicing Regulation
Authors
Woan Ting Tay
Yibin Wang
Publication date
01-12-2025
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 1/2025
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-025-02271-2
This content is only visible if you are logged in and have the appropriate permissions.

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME